样式: 排序: IF: - GO 导出 标记为已读
-
GERM CELL TUMORS IN THE US MILITARY: A CRITICAL ANALYSIS OF PRESENTATION AND TREATMENT Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Tarah Woodle, Eric Umbreit, Leah Williams, Evan Crockett
-
CONCOMITANT NALOXONE AND OPIOID PRESCRIBING ASSOCIATED WITH INCREASED RATES OF SUBSCANCE USE DISORDER AND DEATH FOLLOWING UROLOGIC ONCOLOGIC PROCEDURES Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Sohan S. Shah BS, Brian Im BA, Aaron Hochberg BS, Anushka Ghosh BS, Natalie Perlov BS, Costas D. Lallas MD, Mihir S. Shah MD
-
A NATIONAL ANALYSIS EVALUATING THE ROLE OF LYMPH NODE DISSECTION IN PATIENTS WITH HIGH-RISK UPPER TRACT UROTHELIAL CARCINOMA Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Saad Sabbagh, Mohamed Mohanna, Fernando Cabrera, Barbara Ercole, Nicolas Muruve, Alok Shrivastava, Christopher Weight, Hong Liang, Alberto Pieretti, Surena F. Matin, Rafael Arteta-Bulos
-
UTILITY OF CIRCULATING TUMOR DNA STATUS IN PATIENTS WITH DIFFERENT STAGES OF TESTICULAR CANCER Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Reuben Ben-David, Neeraja Tillu, Che-Kai Tsao, Matthew Galsky, Kyrollis Atallah, Nikhil Waingankar, Peter Wiklund, John P. Sfakianos
-
EVALUATING THE IMPACT OF LYMPOVASCULAR INVASION ON SURVIVAL OF SURGICALLY TREATED PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA: A NATIONWIDE ANALYSIS Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Nicholas Corsi, Giuseppe Ottone Cirulli, Giuseppe Chiarelli, Marco Finati, Matthew Davis, Craig Rogers, Firas Abdollah, Ivan Rakic, Chase Morrsion, Alexander Stephens, Akshay Sood, Giovanni Lughezzani, Andrea Salonia, Nicolò Buffi, Alberto Briganti, Francesco Montorsi, Giuseppe Carrieri
-
UNDERSTANDING THE RELATIONSHIP BETWEEN INSURANCE TYPE AND TESTICULAR GERM CELL TUMORS STAGE PRESENTATION USING THE NATIONAL CANCER DATABASE (NCDB) Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Morgan A. Leff, Khalid Y. Alkatib, Nathaniel Mclauchlan, Brian D. Cortese, I. Mitchell Harmatz, Andrea Yeguez, Majorie Johnson, Daniel S. Roberson, Katharine F. Michel, Benjamin Schurhamer, Daniel J. Lee, S. Bruce Malkowicz, Trinity J. Bivalacqua, Thomas J. Guzzo, Phillip M. Pierorazio, Ruchika Talwar
-
EXAMINING SURVIVAL OUTCOMES AND MOLECULAR DRIVERS OF TESTIS CANCER IN HISPANIC MEN Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Michael E. Rezaee, Roy Elias, Yasser Ged, Nirmish Singla, Maximilian Pallauf
-
IMPACT OF CHEMOTHERAPY ON ANXIETY, DEPRESSION, AND SUICIDALITY AMONGST TESTICULAR CANCER SURVIVORS Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Margaret Meagher, Tyler Nelson, Austin Leonard, Isabella Dolendo, Kylie Morgan, Luke Wang, Daniel Herchenhorn, Tyler Stewart, Juan Javier-Desloges, Amir Salmasi, Rana McKay, Fred Millard, Brent Rose, Aditya Bagrodia, Jacob Taylor
-
CHARACTERIZATION OF VON HIPPEL-LINDAU PATIENTS WITH METASTATIC PHEOCHROMOCYTOMA Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Julie R. Solomon, W. Marston Linehan, Mark W. Ball
-
LONG-TERM OUTCOMES OF SURVEILLANCE OF CLINICAL STAGE I PURE TERATOMA OF THE TESTICLE Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Julian Chavarriaga, Lynn Anson-Cartwright, Robert J Hamilton, Roderick Clark, Eshetu Atenafu
-
PROPENSITY-MATCHED ANALYSIS OF OPEN VERSUS ROBOTIC PRIMARY RETROPERITONEAL LYMPH NODE DISSECTION FOR CS II TESTICULAR CANCER Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Julian Chavarriaga, Carley Langleben, Lynn Anson-Cartwright, Michael Jewett, Robert J. Hamilton, Eshetu Atenafu
-
ASSESSMENT OF PSMA PET IMAGING RESPONSE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER AFTER 225AC-J591 THERAPY: POST-HOC PATIENT-LEVEL ANALYSIS OF A PROSPECTIVE CLINICAL TRIAL Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Andres Ricaurte-Fajardo, Alexander Martinez-Fundichel, Sandra Huicochea Castellanos, Michael Sun, Scott Tagawa, Niel H. Bander, Joseph R. Osborne, Judith Stangl-Kremser
-
DEVELOPMENT AND VALIDATION OF A NOVEL NOMOGRAM TO PREDICT LYMPH NODE INVASION IN UPPER TRACT UROTHELIAL CARCINOMA Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Cesare Saitta, Jonathan A. Afari, Kevin Hakimi, Mimi V. Nguyen, Margaret F Meagher, Luke Wang, Ithaar H. Derweesh, Riccardo Autorino, Savio Pandolfo, Giuseppe Chiarelli, Firas Abdollah, Matthew Davis, Alex Stephens, Spencer H. Bell, Giuseppe Simone, Giovanni Lughezzani, Nicolò M. Buffi, Gabriele Tuderti, Matteo Ferro, Courtney Yong, Chandru P. Sundaram, Marco Tozzi, Jacob Taylor, Vitaly Margulis, Enrico
-
RETHINKING THE DEFINITION OF STAGE IV DISEASE IN ADRENOCORTICAL CARCINOMA: ASSESSING THE IMPACT OF CLININCAL LYMPH NODE POSITIVE DISEASE Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Benjamin Lichtbroun, Helen Gao, Kevin Chua, John Pfail, David Golombos, Thomas Jang, Saum Ghodoussipour, Arnav Srivastava
-
FACTORS ASSOCIATED WITH 30-DAY POST-SURGERY MORTALITY FOLLOWING MAJOR UROLOGIC CANCER SURGERY - CONTEMPORARY ANALYSIS OF THE 2019-2021 NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM (NSQIP) DATA Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Alexis Consalvo, Kevin Chua, John Pfail, Alain Kaldany, Benjamin Lichtbroun, Hiren Patel, David Golombos, Arnav Srivastava, Saum Ghodoussipour, Thomas Jang
-
EVALUATION OF TRANSITIONAL ZONE LESIONS ON MULTIPARAMETRIC MRI AND MRI-TARGETED BIOPSY IN DETECTING CLINICALLY SIGNIFICANT PROSTATE CANCER IN THE COMMUNITY SETTING: A RETROSPECTIVE STUDY Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Zachariah Taylor, Laurence Belkoff, Caroline Buckholtz, Oliver Gibb
-
INTER-RATER RELIABILITY AND DIAGNOSTIC ACCURACY OF PI-RADS SCORING BETWEEN ACADEMIC AND COMMUNITY CARE NETWORKS: HOW WIDE IS THE GAP Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Vinaik Sundaresan, Shayan Smani, Michael Jalfon MD, Justin Nguyen MD, Ghazal Khajir MD, Isaac Y. Kim MD PhD MBA
-
URINARY EXTRACELLULAR VESICLE PROTEINS AS SIGNATURES FOR CRIBRIFORM AND INTRADUCTAL PROSTATE CARCINOMA Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Rui Bernardino, Rashid Sayyid, Neil Fleshner, Ana Sofia Carvalho, Rune Matthiesen, Ricardo Leão, Hermínia Pereira, Luis Campos Pinheiro, Hans Christian Beck, Rui Henrique
-
THE PROGNOSTIC SIGNIFICANCE AND GENETIC PROFILE OF PROSTATE CANCER WITH EXPANSILE CRIBRIFORM GLEASON PATTERN 4 Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Rodrigo Rodrigues Pessoa, Xiaotun Zhang, Reza Nabavizadeh, Sounak Gupta, Alan H Bryce, Laureano J Rangel Latuche, William R Sukov, R Jeffrey Karnes, John C Cheville
-
EFFECT OF TRANSPERINEAL VERSUS TRANSRECTAL PROSTATE BIOPSY ON THE QUALITY OF HYDROGEL SPACER PLACEMENT IN MEN UNDERGOING RADIATION THERAPY FOR PROSTATE CANCER Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Michael E. Rezaee, Ulysses Gardner, Mark N. Alshak, Daniel Y. Song, Michael Goldstein, Christian P. Pavlovich
-
IMPACT OF 18F-DCFPYL PSMA PET ON ACCURACY OF mpMRI IN LOW AND INTERMEDIATE RISK PROSTATE CANCER: INTERIM ANALYSIS OF A PHASE II DIAGNOSTIC TRIAL Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Marcelo P Bigarella, Abigail Wiedmer, Jenna Cava, Tudor Borza, Igor Bereslavskyy, Edward Lawrence, Shane Wells, Steve Cho, David Jarrard
-
UROLOGIST PRACTICE DIVESTMENT FROM RADIATION VAULT OWNERSHIP AND TREATMENT PATTERNS FOR PROSTATE CANCER Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
-
THE EFFECT OF DUAL ELIGIBILITY ON THE QUALITY OF ACTIVE SURVEILLANCE IN PATIENTS WITH NEWLY DIAGNOSED PROSTATE CANCER Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Kassem Faraj, Rodney L Dunn, Lindsey A Herrel, Brent K Hollenbeck
-
DECIPHER® GENOMIC CLASSIFIER SCORE ON INITIAL BIOPSY IS ASSOCIATED WITH PROGRESSION FORM ACTIVE SURVEILLANCE TO TREATMENT IN PROSTATE CANCER Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 John Sheng, Joel Vetter, Nimrod Barashi, James Riley McGinnis, Eric Kim
-
SCREENING WITH PSA AND MRI: YEARLY TRENDS BY PI-RADS AND RACE SHOWS STABLE DIAGNOSIS OF NCCN VERY LOW RISK DISEASE Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Jacob W. Greenberg, Christine Lightfoot, Tivoli Nguyen, Jacob W. Greenberg, Garrett Brinkley, L. Spencer Krane
-
RACIAL EQUITY IN ACTIVE SURVEILLANCE UTILIZATION OF LOW- AND INTERMEDIATE-RISK MEN WITHIN THE PENNSYLVANIA UROLOGIC REGIONAL COLLABORATIVE (PURC) Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 J. Bradley Mason, Z. Deniz Ozisik, Eshrar Choudhury, George Luta, Mohit Gupta, Ross E. Krasnow, Keith J. Kowalczyk, Jay Raman
-
CONDITIONAL SURVIVAL IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Hersh Bendre, Florian Rumpf, Andrew Gusev, Matthew Wszolek, Douglas Dahl, Michael Blute, Adam S. Feldman, Keyan Salari
-
IMPACT OF PROSTATE SIZE ON THE OUTCOMES OF RADICAL PROSTATECTOMY Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Ekamjit Singh Deol, Kelly S Lehner, Anthony E Fadel, Laureano J Rangel, Abhinav Khanna, Matthew K Tollefson, Paras H Shah, Igor Frank, Stephen A Boorjian, Robert J Karnes, Vidit Sharma
-
PROSTATE MRI WITHOUT CONTRAST: OPPORTUNITY TO REDUCE FINANCIAL TOXICITY AND IMPROVE ACCESS FOR PATIENTS WITH PROSTATE CANCER Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Benjamin Pockros MD MBA, Matthew S. Davenport MD, Kristian Stensland MD MPH MS, Rishi Sekar MD, Todd Morgan MD
-
TRANSPERINEAL PROSTATE BIOPSIES WITHOUT ROUTINE ADMINISTRATION OF PERIOPERATIVE ANTIBIOTICS – A SINGLE INSTITUTION RETROSPECTIVE ANALYSIS Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Benjamin Lichtbroun, Mann Patel, Labeeqa Khizir, Munisa Said, Alexis Consalvo, Kevin Chua, John Pfail, David Golombos, Sammy Elsamra, Thomas Jang, Saum Ghodoussipour, Austin Chien, Arnav Srivastava
-
ASSOCIATION BETWEEN DIETARY NUTRIENTS AND INFLAMMATORY POTENTIAL AND BIOPSY UPGRADING IN MEN WITH PROSTATE CANCER ON ACTIVE SURVEILLANCE Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Zhuo Tony Su, Mufaddal Mamawala, Patricia K. Landis, Claire M. de la Calle, Christian P. Pavlovich, Bruce J. Trock, Nitin Shivappa, Michael Wirth, James R. Hébert
-
EVALUATING USE OF A GENETIC RISK SCORE TO IMPROVE PROSTATE CANCER RISK STRATIFICATION IN BLACK MEN: A RETROSPECTIVE PILOT STUDY Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Sean A. Fletcher, Claire M. de la Calle, Guifan Yan, Marta Gielzak, William B. Isaacs, Christian P. Pavlovich, Jianfeng Xu
-
IMPACT OF PI-RADS 5 LESIONS ON ACTIVE SURVEILLANCE FOR GRADE GROUP 1 Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Sarah Azari, J. Bradley Mason, Alexander P. Kenigsberg, Christopher Koller, Sahil Parikh, William Azar, Kyle Schuppe, Jayant Siva, Charles Hesswani, Neil Mendhiratta, Daniel Nethala, Maria Merino, Bradford J. Wood, Peter L. Choyke, Howard L. Parnes, Sandeep Gurram, Baris Turkbey, Peter A. Pinto, Zoë Blake, Daniel R. Nemirovsky, Vladimir Mezhiritsky
-
INCIDENTAL CARCINOMA AFTER SINGLE-PORT TRANSVESICAL ROBOT-ASSISTED SIMPLE PROSTATECTOMY Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Roxana Ramos, Nicolas Soputro, Jaya S. Chavali, Adriana Pedraza, Carter Mikesell, Mohamed Eltemamy, Zeyad Schwen, Jihad Kaouk, Ethan Ferguson
-
DECIPHER® GENOMIC CLASSIFIER ON INITIAL PROSTATE BIOPSY IS ASSOCIATED WITH GLEASON SCORE UPGRADING ON FINAL RADICAL PROSTATECTOMY PATHOLOY Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 John Sheng, Joel Vetter, Nimrod Barashi, James Riley McGinnis, Eric Kim
-
SAFETY OF DRAINLESS MAJOR UROLOGIC SURGERIES: ANALYSIS OF THE 2019-2021 ACS NSQIP DATABASE Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 John Pfail, Alain Kaldany, Kevin Chua, Benjamin Lichtbroun, Rachel Passarelli, Hiren Patel, Arnav Srivastava, David Golombos, Thomas L. Jang, Saum Ghodoussipour
-
INCIDENCE AND FACTORS ASSOCIATED WITH INFECTIOUS COMPLICATIONS FOLLOWING MAJOR UROLOGIC CANCER SURGERIES IN THE UNITED STATES: CONTEMPORARY ANALYSIS OF THE 2019-2021 ACS NSQIP DATABASE Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 John Pfail, Alain Kaldany, Kevin Chua, Benjamin Lichtbroun, Rachel Passarelli, Hiren Patel, Arnav Srivastava, David Golombos, Saum Ghodoussipour, Thomas L. Jang
-
FOCAL THERAPY ELIGIBILITY: AN EVALUATION OF INITIAL AND CONTINUED CANDIDACY FOR FOCAL THERAPY IN A GRADE GROUP 2 ACTIVE SURVEILLANCE COHORT Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 J. Bradley Mason, Sarah Azari, Alex P. Kenigsberg, Zoë Blake, Daniel R. Nemirovsky, Christopher Koller, Sahil Parikh, William Azar, Kyle Schuppe, Charles Hesswani, Neil Mendhiratta, Daniel Nethala, Maria Merino, Peter L. Choyke, Howard L. Parnes, Sandeep Gurram, Baris Turkbey, Bradford Wood, Peter A. Pinto, Vladimir Mezhiritsky
-
A COMPARISON OF MAGNETIC RESONANCE IMAGING-BASED RISK CALCULATORS TO PREDICT PROSTATE CANCER RISK IN EUROPEAN AND NORTH AMERICAN COHORTS Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Hiten D. Patel, Eric V. Li, Adam B Murphy, Ashley E. Ross, Sebastiaan Remmers, Monique J Roobol, Jeffrey L. Ellis, Gopal N. Gupta, Andrew M. Fang, Soroush Rais-Bahrami, Petter Davik
-
DECOMPRESSION OR NOT: THE ONGOING CHALLENGE OF MALIGNANT HYDRONEPHROSIS Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Diana Magee, Emma Helstrom, Spencer Bell, Aroh Pandit, Robert Uzzo, Rosalia Viterbo, David Chen, Marc Smaldone, Alexander Kutikov, Andres Correa
-
TRANSVERSE VERSUS VERTICAL EXTRACTION SITE INCISION AFTER MINIMALLY INVASIVE RADICAL PROSTATECTOMY: A CLINICALLY INTEGRATED, CROSSOVER CLUSTER RANDOMIZED TRIAL Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Christopher D Gaffney, Emily A. Vertosick, Vincent Laudone, Alvin C. Goh, Sigrid V. Carlsson, Eugene Pietzak, Timothy Donahue, Robert Smith, Karim Touijer, Andrew J. Vickers, Behfar Ehdaie
-
GRADE AND VOLUME PROGRESSION AND ITS ASSOCIATION WITH THE DECIPHER GENOMIC CLASSIFIER USING PATIENTS ENROLLED IN A PROSPECTIVE ACTIVE SURVEILLANCE PROTOCOL Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Archan Khandekar, Nachiketh Soodana-Prakash, Sunwoo Han, Isildinha M Reis, Jamie Thomas, Jonathan Ryan, Alan Pollack, Brandon Mahal, Matthew Abramowitz, Alan Dal Pra, Radka Stoyanova, Sandra Gaston, Oleksandr Kryvenko, Yuval Avda, Tarek Ajami, Ankur Malpani, Bruno Nahar, Chad R Ritch, Mark L Gonzalgo, Dipen J Parekh, Sanoj Punnen
-
INTENSIFIED MRI-BASED PROSTATE CANCER SCREENING IN GERMLINE CARRIERS OF RARE PATHOGENIC VARIANTS: INTERIM RESULTS FROM THE INITIAL SCREENING ROUND OF THE PROGRESS STUDY Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Andrew Amini, Alexandra Hunter, Aya Almashad, Aileen J. Feng, Neel D. Patel, Shelley R. McCormick, Linda H. Rodgers, Keyan Salari
-
INTERNATIONAL VARIATIONS IN QUALITY METRICS FOR LOCALIZED PROSTATE CANCER Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Adam B. Weiner MD, Anissa V. Nguyen MPH, Robert E. Reiter MD MBA, Mark S. Litwin MD MPH
-
IMPACT OF BLADDER CUFF MANAGEMENT ON ONCOLOGIC OUTCOMES FOLLOWING RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Abullah Alrumaih, John Kim, Rahul Bansal
-
CHANGES IN PROSTATE SPECIFIC ANTIGEN SCREENING FOLLOWING THE 2018 UNITED STATES PREVENTIVE SERVICES TASK FORCE GUIDELINES AND THROUGH THE COVID-19 PANDEMIC Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Zhiyu (Jason) Qian, Xi Chen, Alexander P. Cole, Hari S. Iyer, Adam S. Kibel, Quoc-Dien Trinh, Firas Abdollah
-
ASSESSING MOLECULAR HETEROGENEITY OF PROSTATE CANCER BIOPSY SAMPLING: INSIGHTS FROM THE MAST TRIAL Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Tarek Ajami, Hui Yu, Nachiketh Soodana-Prakash, Sandra Gaston, Bruno Nahar, Chad Ritch, Mark Gonzalgo, Dipen Parekh, Sanoj Punnen, Radka Stoyanova, Alan Pollack, Brandon Mahal, Oleksandr N Kryvenko
-
COMPARING ACTIVE SURVEILLANCE AND WATCHFUL WAITING AND RADICAL TREATMENT USING MACHINE LEARNING MODELS AMONG PROSTATE CANCER PATIENTS Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 SIQI HU, Chun-Pin Chang, Ankita Date, Carlos Galvao, Benjamin Haaland, Mia Hashibe, John Snyder, Vikrant Deshmukh, Michael Newman, Christina A. Porucznik, Lisa H. Gren, Alejandro Sanchez, Shane Lloyd, Brock O'Neil
-
ASSOCIATION OF PROTON PUMP INHIBITORS CUMULATIVE USE WITH PROSTATE CANCER RISK AND ADVERSE OUTCOMES: A POPULATION-BASED ANALYSIS Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Rashid Sayyid, Raj Tiwari, Zizo Al-Daqqaq, Katherine Lajkosz, Jess G. Cockburn, Rui Bernardino, Majed Al-Rumayyan, Neil E. Fleshner, Bo Zhang, Andrew Wilton, Refik Saskin
-
ELEVATED PERIPROSTATIC VENOUS TESTOSTERONE CORRELATES WITH PROSTATE CANCER PROGRESSION AFTER RADICAL PROSTATECTOMY Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Patrick Durfee Michael, Mohammad Alyamani, Daniel Hettel, Lewis Thomas IV, Scott Lundy, Mike Berk, Mona Patel, Jianbo Li, Hooman Rashidi, Jesse McKenney, Eric Klein, Nima Sharifi
-
OUTPATIENT EXERCISE, NUTRITION, PSYCHOLOGIC SUPPORT, AND PRE-/REHABILITATION FOR PROSTATE CANCER; A SCOPING REVIEW Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Logan Briggs MD, Neil Debarshi BS, Vikram Gill BS, Matthew Van Ligten BS, Kelsey Beck BS, Jaxon Quillen MS, Christopher Dodoo MS, Hider Abdul-Muhsin MD ChB, Mitchell Humphreys MD, Sara Parke MD, P Sarah Psutka M.D., Alicia Morgans MD MPH, Quoc-Dien Trinh MD MBA
-
COMPLICATIONS ASSOCIATED WITH INCREASED LYMPH NODE COUNTS DURING RADICAL PROSTATECTOMY Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Kevin Chua, John Pfail, Alain Kaldany, Alexis Consalvo, Benjamin Lichtbroun, Arnav Srivastava, Sammy Elsamra, David Golombos, Thomas Jang, Saum Ghodoussipour
-
EXPOSURE OF ENVIRONMENTAL TRACE ELEMENTS IN PROSTATE CANCER PATIENTS: RISK ANALYSIS IN MULTIPLE LEVELS Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Hangcheng Fu, Ankem Murali, Chendil Damodaran
-
FACTORS ASSOCIATED WITH PSMA POSITIVITY AT LOW PSA AFTER RADICAL PROSTATECTOMY Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Eric V. Li, Austin Ho, Jonathan Aguiar, Richard Bennett IV, Ashorne K. Mahenthiran, Sai K. Kumar, Chalairat Suk-ouichai, Clayton Neill, Hiten D. Patel, Edward M. Schaeffer, Hatice Savas, Ashley E. Ross
-
OUTCOMES OF TRANSPERINEAL MRI-FUSION TARGETED PROSTATE BIOPSY UTILIZING PRECISIONPOINT VERSUS A GRID TEMPLATE Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Dylan Buller, Maria Antony, Stuart Kesler, Ilene Staff, Tara McLaughlin, Joseph Tortora, Kevin Pinto, Joseph Wagner
-
ROLE OF TUMOR MICROENVIRONMENT DERIVED NRG1 IN ANDROGEN RESISTANCE: IMPLICATIONS FOR A NOVEL PROSTATE CANCER TREATMENT STRATEGY Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Brian Shinder, Ninghui Mao, Nazifa Salsabeel, Zeda Zhang, Charles L. Sawyers, Brett S. Carver
-
ASCERTAINING PROVIDER-LEVEL IMPLICIT BIAS IN THE TREATMENT OF PROSTATE CANCER UTILIZING NATURAL LANGUAGE PROCESSING TECHNIQUES Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Ashwin Ramaswamy, Michael Hung, Joe Pelt, Parsa Iranmahboub, Lina Posada Calderon, Jim C Hu, Christopher Barbieri, Douglas S. Scherr
-
THE IMPACT OF ABDOMINAL INSUFFLATION ON THE INTRAOCULAR PRESSURE DURING ROBOTIC-ASSISTED RADICAL PROSTATECTOMY Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Amir Farooq Khan, Shu Wang, Amanda Ryan, Osamah Saeedi, Mohummad Minhaj Siddiqui
-
COMPARISON OF PARTIAL GLAND CRYOABLATION AND ROBOTIC RADICAL PROSTATECTOMY: A PROPENSITY-SCORE MATCHED ANALYSIS Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Alec Zhu, Emily Cheng, Kshitij Pandit, Mary O. Strasser, Ashwin Ramaswamy, Xiangmei Gu, Jim C. Hu, Sofia Gereta
-
MOLECULAR CORRELATES WITH PSMA EXPRESSION IN PRIMARY PROSTATE CANCER Urol. Oncol. (IF 2.7) Pub Date : 2024-03-14 Adam B. Weiner MD, Nicholas Wang, Raag Agrawal, Ida Sonni, Luca Valle, Amar Kishan, John Shen, Matthew Rettig, Jeremie Calais, Paul Boutros, Robert Reiter, Eric Li, Ashley Ross, Edward Scaheffer, JJ Zhang, Elai Davicioni